Skip to content

Evaluation of conjunctival vascularity after glaucoma surgery using optical coherence tomography Angiography

Evaluation of functional filtering bleb using optical coherence tomography Angiography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003848
Enrollment
95
Registered
2019-04-25
Start date
2017-07-06
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Pusan National University Yangsan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent trabeculectomy with mitomycin as glaucoma in the ophthalmology department of Pusan ??National University Hospital and observed for more than 6 months A person who was previously tested for glaucoma evaluation From December 2016 to August 2017, patients with conjunctival blood vessels were measured using optical coherence tomography Angiography The patients were diagnosed with primary glaucoma or pseudoexfoliation glaucoma, uveitic glaucoma, or steroid-induced glaucoma. Glaucoma surgery is not controlled by ophthalmic eye drops, is not effective on laser, and because of allergy, glaucoma eye drops can not be used.

Exclusion criteria

Exclusion criteria: Of the patients who were included in the study group, patients who did not have a record of optical coherence tomography angiography, patients who had low quality of optical coherence tomography, those who had glaucoma surgery, failed reoperation, or glaucoma eye drops were excluded.

Design outcomes

Primary

MeasureTime frame
Vessel density (brightness density, color density)

Secondary

MeasureTime frame
Comparison of the Indiana Bleb Appearance Grading Scale (IBAGS) and the Moorfields Bleb Grading System (MBGS)

Countries

Korea, Republic of

Contacts

Public ContactJEHYUN SEO

VHS Medical Center

jazmin2@naver.com+82-2-2225-1445

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026